Ariadne Wealth Management LP Takes $1.47 Million Position in Colgate-Palmolive (NYSE:CL)

Ariadne Wealth Management LP purchased a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,185 shares of the company’s stock, valued at approximately $1,474,000. Colgate-Palmolive makes up 0.8% of Ariadne Wealth Management LP’s portfolio, making the stock its 29th largest position.

Several other institutional investors have also recently bought and sold shares of CL. Stonehage Fleming Financial Services Holdings Ltd raised its stake in Colgate-Palmolive by 57.1% in the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after acquiring an additional 139,429 shares during the period. D L Carlson Investment Group Inc. bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $3,269,000. Diversify Advisory Services LLC purchased a new position in shares of Colgate-Palmolive during the first quarter valued at about $911,000. TD Asset Management Inc raised its holdings in Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after purchasing an additional 26,987 shares in the last quarter. Finally, Empowered Funds LLC lifted its position in Colgate-Palmolive by 277.3% during the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after acquiring an additional 24,314 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several analyst reports. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley lifted their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Citigroup raised their price target on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Piper Sandler began coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target on the stock. Finally, BNP Paribas started coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $104.74.

View Our Latest Report on CL

Colgate-Palmolive Trading Up 0.1 %

CL opened at $103.80 on Tuesday. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market cap of $85.16 billion, a price-to-earnings ratio of 32.85, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40. The firm has a 50 day simple moving average of $103.37 and a 200 day simple moving average of $96.53.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.77 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Insiders Place Their Bets

In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Gregory Malcolm sold 10,533 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 in the last quarter. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.